The anti-obesity drug tesofensine* has been shown to be safe in a cardiovascular safety evaluation.
- 1 December 2008
- journal article
- Published by Springer Science and Business Media LLC in Inpharma Weekly
- Vol. 1667 (1667), 11
- https://doi.org/10.2165/00128413-200816670-00035